AI assistant
Sending…
CVS HEALTH Corp — Director's Dealing 2012
Jul 10, 2012
29875_dirs_2012-07-10_f8463146-5886-4113-9ead-21cd887f8ba9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CVS CAREMARK CORP (CVS)
CIK: 0000064803
Period of Report: 2012-07-09
Reporting Person: GOLD STEPHEN J (SVP & CIO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-07-09 | Common Stock | P | 9516 | $47.29 | Acquired | 9516 | Direct |
| 2012-07-09 | Common Stock (pep) | A | 9516 | $47.29 | Acquired | 9516 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-07-09 | Stock Option | $47.29 | A | 95160 | Acquired | 2022-07-09 | Common Stock (95160) | Direct |
Footnotes
F1: Consists of matching Restricted Stock Units awarded pursuant to Issuer's Partnership Equity Program under the 2010 Incentive Compensation Plan. Restrictions lapse on 7/9/2017.
F2: Options become exercisable in three equal annual installments, commencing 07/09/2015.
More from CVS HEALTH Corp
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 7
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
Apr 30
Annual Report
2026
Apr 3
Proxy Solicitation & Information Statement
2026
Apr 3
Proxy Solicitation & Information Statement
2026
Apr 3